Drug‐coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study-Reference-Cited by-同舟云学术

Drug‐coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study

Published:2022-12-08 Issue:1 Volume:101 Page:33-43
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet Cardio Intervent

Author:

Qian Juying¹²,Wu Yizhe¹²,Li Chenguang¹²,Yin Jiasheng¹²,Fu Guosheng³,Wang Jian'an⁴,He Yong⁵,Ma Genshan⁶,Chen Yundai⁷^ORCID,Xia Yong⁸,Li Lang⁹,Ji Fusui¹⁰,Zeng Hesong¹¹,Wei Meng¹²,Nie Shaoping¹³^ORCID,Jin Huigen¹⁴,He Ben¹⁵,Chen Yuguo¹⁶,Liu Fan¹⁷,Wang Hui¹⁸,Sun Yingxian¹⁹,Xu Bo²⁰^ORCID,Ge Junbo¹²,

Affiliation:

1. Department of Cardiology, Zhongshan Hospital Fudan University Shanghai Institute of Cardiovascular Diseases Shanghai China

2. National Clinical Research Center for Interventional Medicine Shanghai China

3. Department of Cardiology, Sir Run Run Shaw Hospital Zhenjiang University School of Medicine Hangzhou China

4. Department of Cardiology The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou China

5. Department of Cardiology West China Hospital of Sichuan University Chengdu China

6. Department of Cardiology Zhongda Hospital Southeast University Nanjing China

7. Department of Cardiology Chinese PLA General Hospital Beijing China

8. Department of Cardiology The Affiliated Hospital of Xuzhou Medical University Xuzhou China

9. Department of Cardiology The First Affiliated Hospital of Guangxi Medical University Nanning China

10. Department of Cardiology Beijing Hospital of the Ministry of Health Beijing China

11. Department of Cardiology, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

12. Department of Cardiology Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University Shanghai China

13. Department of Cardiology, Beijing Anzhen Hospital Capital Medical University Beijing China

14. Department of Cardiology Central Hospital of Putuo District Shanghai China

15. Department of Cardiology, Shanghai Chest Hospital Shanghai Jiaotong University Shanghai China

16. Department of Cardiology Qilu Hospital of Shandong University Ji'nan China

17. Department of Cardiology The Second Hospital of Hebei Medical University Shijiazhuang China

18. Department of Cardiology, Jiangsu Province Hospital The First Affiliated Hospital with Nanjing Medical University Nanjing China

19. Department of Cardiology The First Hospital of China Medical University Shenyang China

20. Department of Cardiology, Fuwai Hospital National Center for Cardiovascular Diseases Beijing China

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.30472

Reference29 articles.

1. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study

2. A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon Versus Paclitaxel-Eluting Stent for the Treatment of Drug-Eluting Stent In-Stent Restenosis

3. Drug-eluting stents to prevent stent thrombosis and restenosis

4. Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome;Feinberg J;Cochrane Database Syst Rev,2017

5. Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical utility of circulating cell division control 42 in small-vessel coronary artery disease patients undergoing drug-coated balloon treatment;BMC Cardiovascular Disorders;2023-10-07

2. Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials;Cardiovascular Therapeutics;2023-08-08